John A Donohue

Title: John A. Donohue: Innovator in Anti-Emetic Pharmaceuticals

Introduction

John A. Donohue is a notable inventor based in Richmond, VA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-emetic compounds. His work has implications for both veterinary and human medicine, showcasing the importance of innovation in healthcare.

Latest Patents

John A. Donohue holds a patent for "Antiemetic N-(1-substituted-4,5-dihydro-1H-pyrazol-4-yl)benzamides." This patent describes compounds that possess gastrokinetic and anti-emetic utility in animals. The compounds are characterized by a general formula where R can be loweralkyl, cycloalkyl, or phenylloweralkyl, and R1 can be selected from various functional groups. The patent also outlines a process for preparing these compounds through the oxidation of 1,2-disubstituted-N-(4-pyrazolidinyl)benzamides with a metal hypochlorite.

Career Highlights

John A. Donohue is associated with A. H. Robins Company, Incorporated, where he has contributed to the advancement of pharmaceutical innovations. His work has led to the development of important therapeutic agents that address nausea and vomiting, enhancing patient care.

Collaborations

Throughout his career, John has collaborated with notable colleagues such as Lennox B. Turnbull and Gunnar E. Jagdmann, Jr. These collaborations have fostered a productive environment for innovation and research in the pharmaceutical industry.

Conclusion

John A. Donohue's contributions to the field of anti-emetic pharmaceuticals highlight the critical role of inventors in advancing medical science. His patent and work at A. H. Robins Company, Incorporated, reflect a commitment to improving healthcare outcomes through innovative solutions.